Ali Bagheri Hagh

Ali Bagheri Hagh

Auto-generated profile, based on publicly available information

Ali Bagheri Hagh

New Hearing Technologies Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2016 in Clinical and Experimental Otorhinolaryngology
Verified
Journal Article
Open access
PDF file
EKEbrahim Karimi
Ebrahim Karimi
SASeyyed Hadi Samimi Ardestani
Seyyed Hadi Samimi Ardestani
MJMehrdad Jafari
Mehrdad Jafari
AHAli Bagheri Hagh
Ali Bagheri Hagh
Free flaps are widely used to reconstruct head and neck defects. Despite the improvement in the surgical techniques and the surgeons' experiences, flap failures still occur due to thrombotic occlusion after small vessels anastomosis. To reduce the possibility of flap loss as a result of thrombotic occlusion, various anticoagulants have been used. In this study we decided to evaluate a new protocol for anticoagulation therapy and its effect on flap survival and complications. In this interventional study, 30 patients with head and neck cancer underwent surgical defects were reconstructed by microvascular free flap between 2013 and 2014. In the postoperative period patients have taken aspirin (100 mg/day) for 5 days and enoxaparin (40 mg/day subcutaneously) for 3 days. The flap survival was followed for three weeks. Given that there was no complete necrosis or loss of flap, the free flap success rate was as much as 100%. The need for re-exploration occurred in 3 patients (10%). Only in one patient the need for re-exploration was due to problem in venous blood flow. The aspirin-enoxaparin short-term protocol may be a good choice after free flap transfer in reconstruction of head and neck surgical defects.

20 January 2012 in Otolaryngology–Head and Neck Surgery
Verified
Journal Article
Closed access
PDF file
MAMojtaba Mohamadi Ardehali
Mojtaba Mohamadi Ardehali
MJMehrdad Jafari
Mehrdad Jafari
AHAli Bagheri Hagh
Ali Bagheri Hagh

6 September 2017
Verified
Book Chapter
Open access
PDF file
Mohammad Hossein KhosraviMohammad Hossein Khosravi
Mohammad Hossein Khosravi
AKAli Kouhi
Ali Kouhi
MSMasoumeh Saeedi
Masoumeh Saeedi
ABAli Bagherihagh
Ali Bagherihagh
MAMohammad Hosein Amirzade-Iranaq
Mohammad Hosein Amirzade-Iranaq
Rapidly increasing trend of thyroid cancer incidence has turned this disease into a global concern. An estimated number of 64,300 new cases of thyroid cancer occurred in men and women in 2016, which represents 3.8% of all new cancer cases of USA (). Thus, there is a high possibility for every physician to encounter a case of thyroid cancer during his/her professional lifetime. In this chapter, we clarified epidemiology, different categories, and new approaches toward diagnosis and management of thyroid cancer.



1 January 2015
Verified
Journal Article
Closed access
SAShahla Afsharpaiman
Shahla Afsharpaiman
ABAli Bagherihagh
Ali Bagherihagh
MNMohammad Kolbadi Nejad
Mohammad Kolbadi Nejad
SASusan Amirsalari
Susan Amirsalari
MTMohammad Torkaman
Mohammad Torkaman